Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease-Reference-Cited by-同舟云学术

Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease

Published:2021-07 Issue: Volume:114 Page:103641
ISSN:1044-7431
Container-title:Molecular and Cellular Neuroscience
language:en
Short-container-title:Molecular and Cellular Neuroscience

Author:

Johannesson Malin,Sahlin Charlotte,Söderberg Linda,Basun Hans,Fälting Johanna,Möller Christer,Zachrisson Olof,Sunnemark Dan,Svensson Anne,Odergren Tomas,Lannfelt Lars

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Reference40 articles.

1. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain;Alic;Mol. Psychiatry,2020

2. The pattern of amyloid accumulation in the brains of adults with Down syndrome;Annus;Alzheimers Dement.,2016

3. Elucidating Pathogenic Mechanisms of Early-onset Alzheimer’s Disease in Down Syndrome Patients;Asai;Yakugaku Zasshi,2017

4. Methodological variables in the assessment of beta amyloid neurotoxicity;Busciglio;Neurobiol. Aging,1992

5. Correlations of synaptic and pathological markers with cognition of the elderly;Dickson;Neurobiol. Aging,1995

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice;Molecular and Cellular Neuroscience;2024-09

2. Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains;Molecular and Cellular Neuroscience;2024-09

3. Lecanemab and Vascular-Amyloid Deposition in Brains of People With Down Syndrome;JAMA Neurology;2024-08-19

4. Profiling lecanemab as a treatment option for Alzheimer’s disease;Expert Review of Neurotherapeutics;2024-04-03

5. Alzheimer’s drugs, APPlication for Down syndrome?;Ageing Research Reviews;2024-04